DAL vs EDIT
Delta Air Lines Inc (DAL) versus Editas Medicine Inc (EDIT) — a side-by-side from cached financials, not a winner call.
Delta Air Lines Inc (DAL) is a airlines company listed on US. It is led by Ed Bastian.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Latest reported DAL revenue for 2024-12-31 was $61.64B. Net income was $3.46B. Revenue was up 6.2% from 2023-12-31 to 2024-12-31. DAL currently screens at market cap $52.18B and trailing P/E 11.6.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
DAL currently screens at market cap $52.18B and trailing P/E 11.6. EDIT currently screens at market cap $375.2M.
Not investment advice. Open the DAL and EDIT stock pages for the full models.
Not investment advice.